NeuroKaire
NeuroKaire, formerly GenetikaPlus, is revolutionizing psychiatry and neurology by integrating precision medicine with AI and stem cell technology. They utilize a Nobel Prize-winning method to derive patient-specific neurons from blood samples. These neurons are then used to predict optimal medication for CNS diseases, informed by genetics, medical history, and the unique response of the patient's brain cells. Their platform offers multi-modal insights from a comprehensive biobank, combining clinical data, imaging features, and RNA transcripts. NeuroKaire serves clinicians, biopharma companies, and patients, aiming to eliminate suffering and optimize treatment outcomes by providing deep mechanistic insights into diseases and drug efficacy.
NeuroKaire
NeuroKaire, formerly GenetikaPlus, is revolutionizing psychiatry and neurology by integrating precision medicine with AI and stem cell technology. They utilize a Nobel Prize-winning method to derive patient-specific neurons from blood samples. These neurons are then used to predict optimal medication for CNS diseases, informed by genetics, medical history, and the unique response of the patient's brain cells. Their platform offers multi-modal insights from a comprehensive biobank, combining clinical data, imaging features, and RNA transcripts. NeuroKaire serves clinicians, biopharma companies, and patients, aiming to eliminate suffering and optimize treatment outcomes by providing deep mechanistic insights into diseases and drug efficacy.